IM Cannabis Corp. reported third‑quarter 2025 revenue of $13.9 million, the same figure as the prior year’s quarter, indicating a flat top line. Gross profit fell 13 percent, and the gross margin slipped from 23 percent in Q3 2024 to 20 percent in Q3 2025. The decline is largely attributable to a $3.1 million non‑cash impairment of goodwill and intangible assets, a charge that reflects the company’s reassessment of asset values amid regulatory uncertainty in its German market.
The earnings release did not include an earnings‑per‑share figure, and management did not provide a consensus estimate for the quarter. Because the company did not disclose EPS or guidance, investors must rely on the revenue and margin data to gauge performance. The flat revenue, combined with margin compression, signals that the company is experiencing headwinds that are not offset by growth in its core markets.
CEO Oren Shuster described 2025 as a “transition year,” noting that the company is “assessing selective new business activities to broaden our growth avenues and support long‑term value creation.” He also highlighted the impact of potential regulatory changes in Germany, which could further constrain sales in that key market.
Management did not issue forward guidance for the next quarter or the full year. The absence of guidance suggests that the company is maintaining a cautious outlook while it navigates the current regulatory environment and the effects of the goodwill impairment.
The combination of flat revenue, declining gross margin, and a significant impairment charge paints a picture of a company in a period of strategic reassessment. While the company’s top line remains stable, the margin squeeze and asset write‑down indicate that profitability is under pressure, and the transition‑year narrative signals that management is exploring new opportunities to offset these challenges. Investors will likely monitor how the company’s new initiatives and regulatory developments in Germany influence future earnings.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.